Cargando…
Celiac Anti-Type 2 Transglutaminase Antibodies Induce Phosphoproteome Modification in Intestinal Epithelial Caco-2 Cells
BACKGROUND: Celiac disease is an inflammatory condition of the small intestine that affects genetically predisposed individuals after dietary wheat gliadin ingestion. Type 2-transglutaminase (TG2) activity seems to be responsible for a strong autoimmune response in celiac disease, TG2 being the main...
Autores principales: | Paolella, Gaetana, Caputo, Ivana, Marabotti, Anna, Lepretti, Marilena, Salzano, Anna Maria, Scaloni, Andrea, Vitale, Monica, Zambrano, Nicola, Sblattero, Daniele, Esposito, Carla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877280/ https://www.ncbi.nlm.nih.gov/pubmed/24391952 http://dx.doi.org/10.1371/journal.pone.0084403 |
Ejemplares similares
-
Gliadin Peptides Induce Tissue Transglutaminase Activation and ER-Stress through Ca(2+) Mobilization in Caco-2 Cells
por: Caputo, Ivana, et al.
Publicado: (2012) -
Constitutive Differential Features of Type 2 Transglutaminase in Cells Derived from Celiac Patients and from Healthy Subjects
por: Paolella, Gaetana, et al.
Publicado: (2020) -
Interplay between Type 2 Transglutaminase (TG2), Gliadin Peptide 31-43 and Anti-TG2 Antibodies in Celiac Disease
por: Martucciello, Stefania, et al.
Publicado: (2020) -
Enzymatic Strategies to Detoxify Gluten: Implications for Celiac Disease
por: Caputo, Ivana, et al.
Publicado: (2010) -
Type 2 Transglutaminase in Coeliac Disease: A Key Player in Pathogenesis, Diagnosis and Therapy
por: Paolella, Gaetana, et al.
Publicado: (2022)